Research Article
Advances in Surface Plasmon Resonance-Based Biosensor Technologies for Cancer Cell Detection
Table 3
Performance parameters when layer of TiSi
2 and layer of BP =
at 633 nm wavelength.
| Type of cell | RI of cell | Targeted RI | Minimum reflectance | S | θ1 | θ2 | FWHM | DA | FoM |
| Basal (skin cancer) | 1.38 | 1.38 | 0.33046 | 195.4 | 75.26 | 80.6 | 5.38 | 0.19 | 36.32 | Basal (normal cell) | 1.36 | 1.36 | 0.27794 | 167.6 | 72.04 | 77.1 | 5.04 | 0.20 | 33.25 | HeLa (cervical cancer) | 1.392 | 1.39 | 0.38627 | 212.4 | 77.24 | 82.4 | 5.2 | 0.19 | 40.85 | HeLa (normal cell) | 1.368 | 1.365 | 0.28677 | 168.4 | 72.78 | 77.9 | 5.16 | 0.19 | 32.64 | Jurkat (blood cancer) | 1.39 | 1.39 | 0.38627 | 212.4 | 77.24 | 82.4 | 5.2 | 0.19 | 40.85 | Jurkat (normal cell) | 1.376 | 1.375 | 0.31213 | 186.6 | 74.38 | 79.7 | 5.35 | 0.19 | 34.88 | PCI-2 (adrenal gland cancer) | 1.395 | 1.395 | 0.42904 | 218.6 | 78.4 | 83.2 | 4.83 | 0.21 | 45.26 | PCI-2 (normal cell) | 1.381 | 1.38 | 0.33046 | 195.4 | 75.26 | 80.6 | 5.38 | 0.19 | 36.32 | MDA-MB-231 (breast cancer) | 1.399 | 1.4 | 0.48642 | 203.6 | 79.8 | 83.8 | 4.01 | 0.25 | 50.77 | MDA-MB-231 (normal cell) | 1.385 | 1.385 | 0.35444 | 202.6 | 76.2 | 81.6 | 5.36 | 0.19 | 37.80 | MCF-7 (breast cancer) | 1.401 | 1.4 | 0.48642 | 203.6 | 79.8 | 83.8 | 4.01 | 0.25 | 50.77 | MCF-7 (normal cell) | 1.387 | 1.385 | 0.35444 | 202.6 | 76.2 | 81.6 | 5.36 | 0.19 | 37.80 |
|
|